(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and ...

London: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as ...

Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...

The 15 largest deals announced in the UK during January have been revealed by new Insider research, with the transactions covering a range of sectors.

GSK's former head of vaccines R&D – Dr Emmanuel ... a vaccine against respiratory syncytial virus (RSV) infections. The London-based company was founded by venture capital firm Medicxi in ...

Prince Harry appeared in a surprise video for the 2025 WellChild Awards on Tuesday, Jan. 28, and asked people to submit ...

Eight new members have been appointed to the Council that advises the Prime Minister and Cabinet on science and technology.

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Prince Harry surprises fans with a heartfelt video supporting the 2025 WellChild. See what the Duke of Sussex had to say here ...